Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
KT Wave moves up 16 positions to #76 in Amazon Sales
"#76 in Muscle Stimulators & Accessories"
Go BIEL !!!
Go KT Wave !!!
Thanks JGD, Adcock has a very professional ActiPatch site up and running!!
https://actipatch.co.za/actipatch-contact-us/
https://actipatch.co.za/why-actipatch/
https://actipatch.co.za/clinical-eveidence/
https://actipatch.co.za/actipatch-frequently-asked-questions/
A little common sense says this is 'Recovery' of 'Medical Billing Accounts Receivable'
"A/R Recovery Specialists for the medical industry"
"Maintain Respectable Average Aging Results
We can provide a road-map to continued low A/R percentage results."
'Aging' is an accounting term.
"Getting started
We'll help you recover your problem A/R. Fast!"
Curious, how does ENDV, with a current Market Cap of $3.67 million, create "in excess of $50 million" of value in SofPulse by splitting it off as a separate company?
Endv paid $4mil for SofPulse 4 years ago and has done little to nothing with it.
Looking at Pulse Therapeutics they appear to be a company working on a device to clear blood clots not an "International Distributor".
Just tried it 3x and worked fine from my computer, are you registered with Linkedin?
https://www.linkedin.com/company/kitotech-medical-inc./
You are the one who asked " Who is this Abhijeet Chaturvedi guy "
A person's business experience is essential in answering that question.
Runing a large company like AMBE Group, with divisions in Manufacturing, Trading, Real Estate, and Banking, for 11 years tells me that he is a capable manager of anything he wants to take on.
AMBE history under Mr. Chaturvedi:
2000 - Established Shiwani Complex (office building)
2004 - Established AMBE Cement LTD
2005 - Established AMBE Complex (office building)
2008 - Established AMBE Housing, Metro Housing, Noodle Factory
2009 - Established AMBE Steels LTD
2011 - Established Commerz & Trust Bank
" Who is this Abhijeet Chaturvedi guy "
Synergy Corporation
Managing Director - Abhijeet Chaturvedi, former CEO of the AMBE Group 2000 - 2011 (currently a $300 million USD company), a large conglomerate involved in Manufacturing, Trading, Real Estate, Banking
General Manager - Madhu Paudel, MBA, Law Degree
Area Business Manager - Satchit Thapa, Registered Pharmacist, Masters in Pharmacy
https://ambegroup.com/
Looks Like Synergy is Alive and Well, contrary to some opinions
Saturday, March 4, 2023
KitoTech Medical Inc. Signs Agreement with Synergy Corporation for International Distribution of Their Medical and Consumer Products
KitoTech Medical has formed a partnership with Synergy Corporation to commercialize its microMend® and microMend® PRO wound closure products in 27 countries around the world.
KitoTech Medical has formed a partnership and signed an exclusive agreement with Synergy Corporation, a leading worldwide distributor of healthcare products, to commercialize its medical and consumer wound closure products, microMend® and microMend® PRO, respectively. The products will be sold in 27 countries in Asia, the Middle East, Africa, and Eastern Europe which represent 25% of the world’s wound closure procedures.
“KitoTech selected Synergy as our international distributor given their proven track record for marketing and selling premium healthcare products including several used to treat wounds,” said Ron Berenson, KitoTech’s President and CEO. “We believe this partnership will create a significant commercial opportunity for microMend and microMend PRO and look forward to working with Synergy to expand the market for our products worldwide.”
“We value the synergies between our company and KitoTech Medical to bring quality healthcare to the developing world,” stated Abhijeet Chaturvedi, Managing Director of Synergy Corporation.
https://www.prweb.com/releases/2023/03/prweb19198552.htm
Selling stock requires both a Seller and a Buyer
<<<<<<<<< You have an immediate double of your money >>>>>>>>>
As I have said several times, there is no market for billions of BIEL shares unless BIEL becomes profitable. That 50% conversion discount is worthless if no one wants to buy the shares. It is "laughable" to think that some do not comprehend this.
BIEL lenders take a risk just as BIEL shareholders do. The fact that BIEL insiders, who have a much clearer picture of BIEL, keep loaning more cash to BIEL is an indicator for me.
If your "NO CHOICE" theory was correct why would those same lenders loan another $296k in 2022? (per Q3 data)
It sounds more like my theory, "They did this because they want BIEL to succeed.", is correct.
Issue date ....Amount ... Maturity .... Noteholder
1/3/2022 ....... $ 50,000 ... 1/3/2024 ....... Richard Staelin
2/4/2022 ....... $ 16,000 ....2/4/2024 ....... St. John's LLC
2/9/2022 ....... $ 40,000 ....2/9/2024 ....... St. John's LLC
6/27/2022 ..... $ 10,000 ....6/27/2024 ..... St. John's LLC
6/24/2022 ..... $ 30,000 ....6/24/2024 ..... Richard Staelin
7/6/2022 ....... $ 25,000 ... 12/31/2022 .... Erin Sanders
7/15/2022 .... $ 100,000 .. 7/15/2024 ...... Richard Staelin
9/15/2022 .... $ 15,000 .... 6/27/2024 ...... St. John's LLC
9/30/2022 .... $ 10,000 .....6/27/2024 ...... St. John's LLC
Total 2022 .... $296,000
Good Grief, the lenders could have demanded payment and BIEL would have had to come up with the cash or the shares
<<<<<<<<< What do you consider all those notes that matured in 2022? >>>>>>>>>
BIEL did not hold a gun to their head and force a loan extension. They all worked with BIEL, as most had done on several previous occasions, rolling the loans over for 2 more years. They did this because they want BIEL to succeed.
Ruh-Roh, KT Wave Climbs 16 places on Amazon Best Sellers
<<<<<<< KT~Recovery+Wave, #102 on Amazon muscle stimulators >>>>>>>
"#86 in Muscle Stimulators & Accessories"
If the CanCapital loan was in default I am sure they would have filed legal action against BIEL by now
Let me know when you find the documentation of that lawsuit.
Until that time, "There are no delinquent operating loans".
There are no "delinquent operating loans"
In the case of the convertible loans the lenders have either chosen to convert and been paid back with shares or have chosen to roll over the loans for another 2 years.
Regarding the EXIM loan and other financial institution loans, they are all up to date.
Where is our intrepid 'Trades Reporter' today? I will fill in:
Buys = 11.4 million shares
Sells = 3.9 million shares
Neutral = 1.1 million shares
$74,000 is your latest guess, up from the ridiculous "about $5,000" initial declaration
I still believe the truth is much higher based on the number of Cartons and Transactions.
So $74,000 is Miles Away from the Claim of $5,000 , 14x Away
<<<<<<<<< the following assertion >>>>>>>>>
That "assertion", "Synergy is affiliated with major drug companies", is correct but it did leave out one of Synergy's largest Partners per the 52WMB Bill of Lading information.
$5 billion Sun Pharmaceuticals with 932 Transactions with Synergy..
Important to remember that any valuation on a BOL is going to be at a wholesale level from mfg to distributor not the revenue Synergy earns when they sell the product..
Things seem a bit Fishy on your Synergy Trade Data
I also did a free account set up with 52WMB.
Your post says that "the 15 orders add up to about $5000 USD". As shown below the one shipment with details, the 11/26/2022 shipment, is 4,900 cartons.
The product in this shipment is Jardiance 90/25mg, a Type 2 diabetes drug that will cost you $778 a month with no insurance. How can 4,900 cartons of an expensive Type 2 diabetes drug be valued at "about $5,000 USD" ???
And this is just one of the15 shipments mentioned. The free membership does not give details on the other shipments other than the number of cartons. The other shipments total over 43,000 cartons.
Trade date
2022/11/26
B/L No. (not shown)
——
Supplier - boehringer ingelheim c.a.
Buyers - synergy overseas pvt ltd.
Export Port - sahar air cargo acc inbom4
Import Port - kathmandu tribhuva
Supply area - venezuela
Purchasing area - nepal
Cartons - 4,900
Product description - Jardiance 90/25mg
Thanks for documenting your transaction, the order was placed for 911 shares at .0006
The MM that filled it painted it down to .00055 .
It doesn't matter what the number of shares are in the order. On the OTC retail Traders are limited to 4 digits to the right of the decimal point, as in .0006 .
So when you see 5 or more digits to the right of the decimal point, as in .00055, a MM, for whatever reason, has stepped in and modified that transaction.
Total Nonsense, the Lawyers are the Only Ones that get Anything from a class action lawsuit in Pennyland.
I will take Dr Staelins reputation over anyone on this board
Richard Staelin is the Gregory Mario and Jeremy Mario Professor Emeritusof Business Administration at the Fuqua School of Business, Duke University. He joined Duke in 1982 after teaching at Carnegie-Mellon University for 13 years. He has also been on the faculties of the Australian Graduate School of Management and the University of Chicago. He was Editor of Marketing Science and President of ISMS. He has won best paper awards at Marketing Science, JMR and JM and was awarded the Converse Award and the AMA Best Educators Award. He is an inaugural fellow in ISMS and the AMA and a fellow in INFORMS. He was awarded the best teaching award for the DKU program in 2016.
Current Appointments & Affiliations
Gregory Mario and Jeremy Mario Distinguished Professor, Fuqua School of Business, Duke University 2017
Professor Emeritus of Business Administration, Fuqua School of Business, Duke University 2023
Forgot to mention over 4x more Buys than Sells Today
Buys = 4.059 million shares
Sells = 892k shares
Good Grief, the misinformation abounds
There is zero chance that Dr Staelin, BIEL's COB, and St John's, Patricia Whelan, demand repayment of their loans next month. Ken McLeod, a long time BIEL consultant, will probably to the same. If he should demand to be paid back BIEL would need a new loan or an AS increase if the current remaining AS, 295 million shares, would not cover the conversion.
2022 saw One Loan Conversion. That One Conversion was by St John's so that they would have the cash to make new Non-Convertible Loans to BIEL. They made 5 new Non-Convertible Loans to BIEL in 2022. The first one was one week after the Conversion.
<<<<< In 2022 there was a massive amount of those notes that rolled over >>>>>
"Kicking them down the road" does not make the Loans go away but it does prevent near term dilution which benefits all shareholders. Per the loan agreements BIEL has the option to repay the Convertible Loans in Cash or Shares. So if BIEL is generating profits 2 years down the road or is in a better position to secure conventional loans, cash repayment of the Convertible Loans will be an option
Q3 2022 Financials, page 16
"All accrued interest and principal on the various notes payable are due on or before the end of the month two years from the date of issuance, whether by the payment of cash or by conversion into shares of the Company’s common stock, unless otherwise extended with new terms."
Forgot to Mention that all of those Lenders have Rolled Over Loans in the past
LOL, Steamy Load of Horse Hockey, must not have even watched the video
<<<<<<< you must OWN the stock or borrow stock from a broker >>>>>>>>
LOL, just because the SEC has regulations to prevent Naked Shorting doesn't mean everyone follows those rules. It is against the law to commit bank robbery & murder but tens of thousands of people do it every year.
Dealer Brokers and Market Makers who are more interested in profits than SEC regulations cover up their Naked Shorting in various ways, example;
SEC Brings “Naked Short Selling” Case
May 27, 2021
What Did the BD Allegedly Do Wrong?
"According to the Complaint, the BD mismarked 96% of a certain hedge fund’s short sale orders of two separate issuers’ stock, totaling more than $250 million, as “long” or “short-exempt.” This mismarking allegedly generated $1.6 million in brokerage fees to the BD. The effect of the mismarking was that the hedge fund was able to sell the securities short even though it already had a short position in the securities and did not borrow or locate additional shares to sell short."
"The message to the public markets is that naked short selling can indeed be a practice used to drive down the price of an issuer’s stock."
Those who watched the Gimme Greenbacks video saw 4 CEOs discussing the attacks that have occurred on their companies. One had seen a trading volume of 4x the OS in one day.
The typical scenario is that a Hedge Fund wants to short a company to drive the price down but they have already reached the limit on how much they can Short or they don't want the expenses and commitment of capital that legal Shorting requires. They promise a Broker/MM large commissions if they will Naked Short stock "X".
In the case of BD the Broker falsely marks the Naked Shorting transactions as 'Long' or 'Short Exempt'. It's as easy as checking a box on a form.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171251460
****************************************************************************
<<<<<<<<<< UNLESS I AM DUMPING AS IN PREVIOUS WEEKS >>>>>>>>>>>
What the Hell, after 6 years of doing nothing but trash BIEL you are saying that you own BIEL Shares!!
When someone tells you who they Really Are believe them
Thanks GG, contrary to what some on this board want you to think Naked Shorting is alive and well, stealing money from companies and shareholders every day.
Your "Facts" have some Major Fallacies
<<<<<<<< to do who knows what >>>>>>>>>
The FDA was stuck in the 1950's as far as the 'Mechanism of Action' for Shortwave Therapies so unlike many 510Ks that get the 'Me Too' treatment for their 510k Clearance the FDA wanted Clinical proof of efficacy for Pain Relief. BIEL supplied that:
RecoveryRx FDA Cleared on K190251 for Post Operative Pain with 2 Clinical Trials
https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190251.pdf
ActiPatch FDA Cleared on K152432 for Plantar Fasciitis of the Heel/Osteoarthritis of the Knee with 2 Clinical Trials. BIEL had Led the Way in 2015 to secure an FDA Reclassification for ActiPatch from a Class 3 Device, which is for devices like Pacemakers that are life sustaining, to a Class 2 Device which can include OTC Clearance. The FDA created a new Product Code and Name, 'PQY, Nonthermal Shortwave Therapy. This set up the Over the Counter Clearance in in 2017.
https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152432.pdf
ActiPatch 2020 FDA Cleared on K192234 for Musculoskeletal Pain, this includes every muscle, joint and bone in the body, with 3 Clinical Trials, Cervical Osteoarthritis, Osteoarthritis of the Knee and Plantar Fasciitis.
https://www.accessdata.fda.gov/cdrh_docs/pdf19/K192234.pdf
That does not sound like " to do who knows what".
******************************************************************
<<<<<<<<<< BOOTS booted BIEL >>>>>>>>>
BIEL sold successfully in the UK in 2014-2017. ActiPatch sold in over a thousand Boots stores as well as several other pharmacy chains. This retail marketing saw several of BIEL's largest revenue years. However, the costs associated with paying 'Slotting Fees', paying rent for shelf space, in thousands of stores ended up causing some of BIEL's largest yearly losses.
When BIEL received the NHS Approval in 2018 they pulled the ActiPatch from most retail stores feeling that demand would drop at these stores with patients using their NHS coverage.
*********************************************************
<<<<<<<<<<< that clearance came in 2/2016 >>>>>>>>>>>>
There was no FDA Clearance in 2016. The first ActiPatch OTC Clearance came in 2017 for two medical indications, as documented above.
The significant OTC FDA Clearance came in 2020, Musculoskeletal Pain. This meant that Actipatch was now FDA Authorized for Pain on every Muscle. Joint, Ligament, and Bone.
**************************************************************
<<<<<< relationship with the EX-IM bank on supposed " Loan Guarantees" >>>>>>>>
This is no mystery. As BIEL's largest Lender IBEX was granted rights to all BIEL Property as security for the loans. In 2018 when BIEL wanted to extend the EXIM Loans they wanted and received the right to being first in line for BIEL assets, ahead of IBEX.
Q3 2022 Financials page 16
"According to the original Security Agreement dated August 1, 2009, the Company grants IBEX a security interest in, all of the right, title, and interest of the Company, in and to all of the Company’s personal property and intellectual property, and all proceeds or replacements as collateral for the convertible promissory note agreements. The Security Agreement has been subordinated to the EX-IM Bank."
https://www.otcmarkets.com/otcapi/company/financial-report/351692/content
Please Show Me Where BIEL Used Cash to Pay Back a Convertible Loan
<<<<< rollovers are not because the family is suddenly stockholder friendly, it's because there is no money to payback their loans >>>>>
It Has Not Happened. Shares in BIEL are used to pay back the Convertible Loans.
Rolling Over the Convertible Loans helps Stockholders by not diluting their BIEL Shares.
<<<<<< same reason for foregoing the interest >>>>>>
The Interest on Convertible Loans has never been paid back in Cash. It has been added to the Loan and paid back upon Conversion. Geeezzzz!
BIEL could have raised the AS and continued to pay back the Convertible Loans in Stock, diluting existing shareholders, they did not. That sounds "Shareholder Friendly" to me.
As far as Kicking the Loans Down the Road for another 2 years. It takes 20 times more shares to pay off a Convertible Loan at a .0005 SP than at a .01 SP.
The only way IBEX, St John's, Staelin get their Loans repaid is when BIEL is Profitable
<<<<<<<< The note holders must get paid eventually >>>>>>>>>>
IBEX was the only lender who had priority to recover assets in the event of BIEL's BK. IBEX lost this priority to the EXIM Bank several years ago.
The combined debt to the top 3 lenders is over $11 million. BIEL's assets in a BK scenario will not cover this debt. IMO, that is how we know KW, PW, Dr Staelin are doing everything possible to make BIEL a success, it could very well determine if they get their investments repaid.
We saw the commitment to BIEL's success in the millions of dollars in Loan Roll Overs that have occurred. IBEX, St John's and Dr Staelin all have Loans dating back to 2017 that have been Rolled Over numerous times.
We saw the commitment to BIEL's success in the $2.5 million in Interest foregoing over the last 3 years by IBEX and St John's.
We saw the commitment to BIEL's success in the Nonconvertible Loans that St John's and Dr Staelin have made to BIEL over the last two years.
Yep GG, in addition to the timing of the 911 trade the MMs backed way off on the Shorting yesterday with only 1.2 million shares Shorted out of a 6.1 million share total volume.
Nice to see that 3 million share Buy at 3:42 and the Buy/Sell ratio 50k shares away from parity.
date .. symbol .. short vol... total vol
20230217|BIEL|1290911|0|6152303
20230216|BIEL|5659010|0|8129869
20230215|BIEL|2095000|0|2808000
20230214|BIEL|14637723|0|19475631
20230213|BIEL|162000|0|371000
So you would rather have BIEL cease operations rather than work with lenders, Rolling Over loans for another 2 years, giving BIEL and its Partners time to find the correct marketing to educate consumers on PSWT and sell products.
Got it, nice to know where you stand.
As far as Sales not covering operational costs, look at the Net Losses and Dilution 5-10 years ago compared to the period since KW took over and tell me BIEL has not made significant progress towards solvency.
What a Load of BS
<<<<<<<<<<<<< SALES BOTTOM OF THE BARREL >>>>>>>>>>>>>>>
This page displays the 5 products DonJoy lists under its Recovery-Pain Management classification. The 2 'Fast Freeze ' products have been discounted by 68% which is why they currently have more sales.
All three of the 'Powered by ActiPatch' products are priced at the full RRP.
https://www.donjoyperformance.com/pain-management
Didn't your DD show that there was only one Convertible Loan conversion in 2022?
St John's converted a Loan on 1/25/2022 and that was the only one per the Q3 financials.
What did St John's do a week after that conversion? They started making new Loans to BIEL, 5 that we know of, on an Interest Only basis, no conversion to shares option.
Multiple BIEL lenders want BIEL to succeed and are following the lead of IBEX, St John's and Dr Staelin in Rolling Over their Loans for another 2 years.
News Flash, KT Wave is not a 'Muscle Stimulator'
<<<<<<<< #100 on Amazon muscle stimulators >>>>>>>>
The Wave is a PSWT FDA Cleared Medical Device for the Relief of Musculoskeletal Pain.
Said the same thing in October & BIEL is still around 4 months later
<<<<<<<<< the coup de grâce is nigh >>>>>>>>>
Monday, October 10, 2022 3:42:56 PM
"Coming to an end. Finally THIS SCAM IS OVER."
*********************************************************
And May,
Thursday, May 19, 2022 11:24:49 AM
"Biel is DEAD over done with"
*********************************************************
And April,
Wednesday, April 27, 2022 12:09:42 PM
"I am expecting a BK filing frankly."
Same cries of, Wolf, heard over and over again but the Wolf never appears
The truth is BIEL is overdue for news. Yesterday few wanted to Sell at 5 and few wanted to Buy at 6.
Pretty simple.
I would agree with that sentiment Hawk
<<<<<<<<< BIEL should give an update >>>>>>>>>
Only adding that it should have occurred at the end of 2022 or the first week of 2023.
In this context "Interest Only" means Loans are 'Not Convertible', No Conversion into BIEL Shares = No Dilution
<<<<<< forgo interest on their convertible notes for 2020, and continuing into 2022 >>>>>>
Everyone was complaining about the 'Convertible loans' and their 50% discount to the share price.
Dr Staelin & St John's said, OK, and have made No new 'Convertible Loans' since December 10th of 2019. Both parties have continued to Roll Over their old convertible loans for another 2 years as they come due.
For the years 2020, 2021 & 2022 IBEX and St John's have forgone Interest on their Convertible Loans. This has saved BIEL $2.5 million.
Kelly Whelan's last new loan was initiated on 10/17/2019. Her last loan conversion to shares was on 3/22/2019. Since March of 2019 she has extended all her loans for two more years as they came due.
More Scare Tactics, All These Lenders Have Rolled Over Loans Previously
Ken McLeod, BIEL Consultant
Dr Staelin, BIEL Chairman of the Board, $550k in Interest Only Loans since return to COB
St John's, controlled by Patricia Whelan, $81k in Interest Only Loans in 2022
That was a MM Parlor Trick
<<<<<<<<< look at today's price results 0.00045 >>>>>>>>>>
A Market Maker executed this $27 trade at 9:30:00 to try and create a negative sentiment among traders . Anytime a Trading price with five digits to the right of the decimal point shows up it comes from a MM/Broker-Dealer because retail traders can not place an order with 5 or more digits right of the decimal point.
The 5 Bid Size is now 13 million shares.